• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Senseonics Holdings, Inc.

    4/23/21 5:14:51 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials
    Get the next $SENS alert in real time by email
    SC 13G 1 p21-1215sc13g.htm SENSEONICS HOLDINGS, INC.

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     
    SCHEDULE 13G
     
     
    Under the Securities Exchange Act of 1934
     
    (Amendment No.  )*
     

    Senseonics Holdings, Inc.

    (Name of Issuer)
     

    Common Stock, par value $0.001 per share

    (Title of Class of Securities)
     

    81727U105

    (CUSIP Number)
     

    April 13, 2021

    (Date of event which requires filing of this statement)
     
     
    Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:
     
    ¨ Rule 13d-1(b)
    x Rule 13d-1(c)
    ¨ Rule 13d-1(d)
     
    (Page 1 of 7 Pages)

     

    ______________________________

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    CUSIP No. 81727U10513GPage 2 of 7 Pages

     

    1

    NAMES OF REPORTING PERSONS

    Highbridge Capital Management, LLC

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    State of Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    22,920,231 shares of Common Stock (including 2,750,000 shares of Common Stock issuable upon exercise of warrants and 20,170,231 shares of Common Stock issuable upon conversion of convertible notes)

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    22,920,231 shares of Common Stock (including 2,750,000 shares of Common Stock issuable upon exercise of warrants and 20,170,231 shares of Common Stock issuable upon conversion of convertible notes)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    22,920,231 shares of Common Stock (including 2,750,000 shares of Common Stock issuable upon exercise of warrants and 20,170,231 shares of Common Stock issuable upon conversion of convertible notes)

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    5.08%

    12

    TYPE OF REPORTING PERSON

    IA, OO

             

     

     

    CUSIP No. 81727U10513GPage 3 of 7 Pages

     

     

    Item 1(a). NAME OF ISSUER:
       
      The name of the issuer is Senseonics Holdings, Inc. (the "Company").

     

    Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
       
      The Company's principal executive offices are located at 20451 Seneca Meadows Parkway, Germantown, MD 20876-7005.

     

    Item 2(a). NAME OF PERSON FILING:

     

    Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

     

    Item 2(c). CITIZENSHIP:

     

      This statement is filed by:
       
      (i)

    Highbridge Capital Management, LLC

    277 Park Avenue, 23rd Floor

    New York, New York 10172

    Citizenship: State of Delaware

       
      The foregoing person is hereinafter sometimes referred to as the "Reporting Person."  

     

    Item 2(d). TITLE OF CLASS OF SECURITIES:
       
      Common Stock, par value $0.001 per share (the "Common Stock").

     

    Item 2(e). CUSIP NUMBER:
       
      81727U105

     

    Item 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b) OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:

     

      (a) ¨ Broker or dealer registered under Section 15 of the Act,
      (b) ¨ Bank as defined in Section 3(a)(6) of the Act,
      (c) ¨ Insurance Company as defined in Section 3(a)(19) of the Act,
      (d) ¨ Investment Company registered under Section 8 of the Investment Company Act of 1940,
      (e) ¨ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
      (f) ¨ Employee Benefit Plan or Endowment Fund in accordance with Rule 13d-1(b)(1)(ii)(F),

     

    CUSIP No. 81727U10513GPage 4 of 7 Pages

     

     

      (g) ¨ Parent Holding Company or control person in accordance with Rule 13d-1(b)(1)(ii)(G),
      (h) ¨ Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act,
      (i) ¨ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
      (j) ¨ A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
      (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

     

      If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please
      specify the type of institution:  

     

    Item 4. OWNERSHIP.
       
     

    (a)       Amount beneficially owned:

     

    As of the date hereof, Highbridge Capital Management, LLC, as the trading manager of Highbridge Tactical Credit Master Fund, L.P. and Highbridge Convertible Dislocation Fund, L.P. (collectively, the "Highbridge Funds"), may be deemed to be the beneficial owner of the 22,920,231 shares of Common Stock (including 2,750,000 shares of Common Stock issuable upon exercise of warrants and 20,170,231 shares of Common Stock issuable upon the conversion of convertible notes) held by the Highbridge Funds.

     

    (b)       Percent of class:

     

    The percentages used herein and in the rest of this Schedule 13G are calculated based upon 427,914,984 shares of Common Stock reported to be outstanding as of April 5, 2021, as reported in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 13, 2021, and assumes the exercise of the warrants and the conversion of the convertible notes reported herein. Therefore, as of the date hereof, Highbridge Capital Management, LLC may be deemed to beneficially own approximately 5.08% of the outstanding shares of Common Stock.

     

    The foregoing should not be construed in and of itself as an admission by the Reporting Person as to beneficial ownership of the shares of Common Stock issuable upon exercise of the warrants or conversion of the convertible notes held by the Highbridge Funds.

     

    CUSIP No. 81727U10513GPage 5 of 7 Pages

     

     

     

     

     

    (c)       Number of shares as to which such person has:

     

    (i)       Sole power to vote or to direct the vote

     

    0

     

    (ii)       Shared power to vote or to direct the vote

     

    See Item 4(a)

     

    (iii)       Sole power to dispose or to direct the disposition of

     

    0

     

    (iv)       Shared power to dispose or to direct

    the disposition of

     

    See Item 4(a)

     

    Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
       
      Not applicable.

     

    Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
       
      Not applicable.

     

    Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
       
      Not applicable.

     

    Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
       
      Not applicable.

     

    Item 9. NOTICE OF DISSOLUTION OF GROUP.
       
      Not applicable.

     

    CUSIP No. 81727U10513GPage 6 of 7 Pages

     

     

    Item 10. CERTIFICATION.

     

      The Reporting Person hereby makes the following certification:
       
      By signing below the Reporting Person certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

    CUSIP No. 81727U10513GPage 7 of 7 Pages

     

     

    SIGNATURES

    After reasonable inquiry and to the best of our knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

    DATED: April 23, 2021

     

    HIGHBRIDGE CAPITAL MANAGEMENT, LLC
         
         
    By: /s/ Kirk Rule  
    Name: Kirk Rule  
    Title: Executive Director  
         

     

    Get the next $SENS alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SENS

    DatePrice TargetRatingAnalyst
    8/27/2025$1.50Overweight
    Barclays
    7/15/2025$1.25Buy
    TD Cowen
    6/2/2025$1.10Buy
    H.C. Wainwright
    4/10/2025$2.00Outperform
    Mizuho
    7/19/2023$0.50Underperform
    Jefferies
    8/19/2021$6.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $SENS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ascensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner Senseonics

    - Agreement with Senseonics to transfer commercial activities would integrate Eversense manufacturing and distribution to accelerate growth PHC Holdings Corporation (President, Representative Director and CEO: Kyoko Deguchi, TSE: 6523) and its subsidiary Ascensia Diabetes Care, a global diabetes care company, today announced that Ascensia has signed a memorandum of understanding to transfer the commercial operations for Eversense® Continuous Glucose Monitoring (CGM) systems to Eversense maker Senseonics Holdings, Inc. (NYSE:SENS). The companies are targeting to unite Eversense R&D, manufacturing, and commercial activities within Senseonics beginning January 1, 2026, subject to a definitiv

    9/3/25 7:22:00 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

    CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million with Hercules Capital to fund commercial organization Conference Call scheduled for September 4, 2025 at 8:00 A.M. Eastern Time GERMANTOWN, Md., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced a mutually executed Memorandum of Understanding to transition all commercialization and distributio

    9/3/25 5:17:09 PM ET
    $HTGC
    $SENS
    Investment Managers
    Finance
    Industrial Machinery/Components
    Industrials

    Senseonics Holdings, Inc. Reports Second Quarter Financial Results

    Generated Q2 revenue of $6.6 million, representing year-over-year growth of 37% Achieved a 79% increase in U.S. new patient starts over prior year GERMANTOWN, Md., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the second quarter ended June 30, 2025. Recent Highlights & Accomplishments: Generated revenue of $6.6 million in the second quarter of 2025, an increase of 37% versus the second quarter of 2024, driven by 79% new patient growth in the U.S. over prio

    8/6/25 4:05:00 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Prince Douglas S was granted 17,069 shares, increasing direct ownership by 2% to 1,087,607 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    7/3/25 4:15:40 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Director Steven Edelman was granted 27,048 shares, increasing direct ownership by 2% to 1,263,001 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    7/3/25 4:15:32 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Director Roeder Douglas A was granted 30,987 shares, increasing direct ownership by 2% to 1,658,826 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    7/3/25 4:15:35 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    SEC Filings

    View All

    SEC Form EFFECT filed by Senseonics Holdings Inc.

    EFFECT - Senseonics Holdings, Inc. (0001616543) (Filer)

    8/19/25 12:15:16 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    SEC Form 424B3 filed by Senseonics Holdings Inc.

    424B3 - Senseonics Holdings, Inc. (0001616543) (Filer)

    8/18/25 4:36:27 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    SEC Form DEF 14A filed by Senseonics Holdings Inc.

    DEF 14A - Senseonics Holdings, Inc. (0001616543) (Filer)

    8/18/25 7:30:29 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $SENS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Amendment: Director Roeder Douglas A bought $37,500 worth of shares (75,000 units at $0.50), increasing direct ownership by 5% to 1,463,087 units (SEC Form 4)

    4/A - Senseonics Holdings, Inc. (0001616543) (Issuer)

    12/20/24 5:37:53 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Director Roeder Douglas A bought $135,500 worth of shares (325,000 units at $0.42), increasing direct ownership by 30% to 1,413,087 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    12/16/24 4:21:25 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Chief Financial Officer Sullivan Frederick T. bought $47,475 worth of shares (124,933 units at $0.38), increasing direct ownership by 5% to 2,478,844 units (SEC Form 4)

    4 - Senseonics Holdings, Inc. (0001616543) (Issuer)

    12/12/24 7:04:14 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Barclays initiated coverage on Senseonics with a new price target

    Barclays initiated coverage of Senseonics with a rating of Overweight and set a new price target of $1.50

    8/27/25 8:26:33 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    TD Cowen initiated coverage on Senseonics with a new price target

    TD Cowen initiated coverage of Senseonics with a rating of Buy and set a new price target of $1.25

    7/15/25 8:44:36 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    H.C. Wainwright resumed coverage on Senseonics with a new price target

    H.C. Wainwright resumed coverage of Senseonics with a rating of Buy and set a new price target of $1.10

    6/2/25 8:54:33 AM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    Financials

    Live finance-specific insights

    View All

    Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

    CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million with Hercules Capital to fund commercial organization Conference Call scheduled for September 4, 2025 at 8:00 A.M. Eastern Time GERMANTOWN, Md., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced a mutually executed Memorandum of Understanding to transition all commercialization and distributio

    9/3/25 5:17:09 PM ET
    $HTGC
    $SENS
    Investment Managers
    Finance
    Industrial Machinery/Components
    Industrials

    Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time

    GERMANTOWN, Md., July 16, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its second quarter 2025 financial results after market close on Wednesday, August 6, 2025. Management will hold a conference call to review the Company's second quarter 2025 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by na

    7/16/25 4:05:00 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    Senseonics Holdings, Inc. Reports First Quarter Financial Results

    Q1 Revenue of $6.3 million, growth year over year of 24% Partnership with Sequel integrates twiist™ automated insulin delivery (AID) system with Eversense® 365 one-year continuous glucose monitor (CGM); twiist with Eversense 365 launch expected in Q3 GERMANTOWN, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE:SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the first quarter ended March 31, 2025. Recent Highlights & Accomplishments: Generated revenue of $6.3 million in the first quarter of 2025CMS upda

    5/8/25 4:05:00 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    $SENS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Senseonics Holdings Inc. (Amendment)

    SC 13G/A - Senseonics Holdings, Inc. (0001616543) (Subject)

    2/13/24 5:13:59 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G/A filed by Senseonics Holdings Inc. (Amendment)

    SC 13G/A - Senseonics Holdings, Inc. (0001616543) (Subject)

    7/7/23 4:35:55 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G filed by Senseonics Holdings Inc.

    SC 13G - Senseonics Holdings, Inc. (0001616543) (Subject)

    4/10/23 5:10:45 PM ET
    $SENS
    Industrial Machinery/Components
    Industrials